Dependency of the effect of a vascular disrupting agent on sensitivity to tirapazamine and γ-ray irradiation upon the timing of its administration and tumor size, with reference to the effect on intratumor quiescent cells

Author： Masunaga Shin-ichiro   Nagasawa Hideko   Nagata Kenji   Suzuki Minoru   Uto Yoshihiro   Hori Hitoshi   Kinashi Yuko   Ono Koji  

Publisher： Springer Publishing Company

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.133, Iss.1, 2007-01, pp. : 47-55

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells

By Masunaga S.   Ono K.   Hori H.   Kinashi Y.   Suzuki M.   Takagaki M.   Kasai S.   Nagasawa H.   Uto Y.  

International Journal of Hyperthermia, Vol. 15, Iss. 1, 1999-01 ,pp. : 7-16

Informa Healthcare

Access to resources Recommend Favorite

ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapy

By Baguley Bruce C   McKeage Mark J  

Future Oncology, Vol. 6, Iss. 10, 2010-10 ,pp. : 1537-1543

Future Medicine

Access to resources Recommend Favorite

The Effect of Total-body γ-irradiation on Pigeons

By Gadhia P.K.   Shah V.C.   Desai Ramesh  

International Journal of Radiation Biology, Vol. 35, Iss. 5, 1979-05 ,pp. : 493-495

Informa Healthcare

Access to resources Recommend Favorite

Usefulness of combined treatment with continuous administration of tirapazamine and mild temperature hyperthermia in &ggr;-ray irradiation in terms of local tumour response and lung metastatic potential

By Masunaga Shin-Ichiro   Liu Yong   Sakurai Yoshinori   Tanaka Hiroki   Suzuki Minoru   Kondo Natsuko   Maruhashi Akira   Ono Koji  

International Journal of Hyperthermia, Vol. 28, Iss. 7, 2012-11 ,pp. : 636-644

Informa Healthcare

Access to resources Recommend Favorite

Combretastatin A4 phosphate: a novel vascular disrupting agent

By Nagaiah Govardhanan   Remick Scot C  

Future Oncology, Vol. 6, Iss. 8, 2010-08 ,pp. : 1219-1228

Future Medicine

Access to resources Recommend Favorite